Phase I trial of CH 4051 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2010
At a glance
- Drugs CH 4051 (Primary)
- Indications Arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- 27 Sep 2010 Status changed from recruiting to completed, according to a Chelsea Therapeutics media release.
- 03 Nov 2009 Results presented at 2009 Annual Scientific Meeting of the American College of Rheumatology.
- 21 Oct 2009 Results were presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals (ACR/ARHP-2009)
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History